The University of Minnesota’s Epilepsy Center is proud to share a new case study that underscores the power of innovation, collaboration, and patient-centered care—especially for women navigating epilepsy during pregnancy.
At the center of this work is Dr. Aisha Abdul Razaq, whose leadership and expertise continue to elevate care within the Women’s Health and Epilepsy Clinic at the U. Her dedication to advancing safe, comprehensive treatment options for women with epilepsy is making a profound impact on clinical practice and patient outcomes.
This newly released case study demonstrates how anti-seizure medications can be safely managed during pregnancy when combined with RNS (Responsive Neurostimulation) device therapy. The RNS system not only delivers responsive electrical stimulation to reduce seizure activity—it also functions as an electronic seizure diary, giving clinicians a more complete and real-time picture of seizure patterns throughout pregnancy.
This careful integration of technology and medication management supports better monitoring, individualized treatment adjustments, and improved safety for both mother and baby.
The study was co-authored by Drs. Aisha Abdul Razaq, Sandip Pati, et al, reflecting a strong collaborative effort across disciplines within the Epilepsy Center and the broader MnDRIVE and UMN health community.
The University of Minnesota’s Women’s Health and Epilepsy Clinic continues to lead the way in providing specialized, compassionate care for women with epilepsy across all stages of life—including those who are pregnant or planning a family.
This case study adds to a growing body of evidence showing that with expert oversight and advanced neurotechnology, women with epilepsy can experience safer, more informed pregnancies. We are excited to highlight this work and the remarkable clinicians behind it.
